2015-2019 European Infectious Disease Testing Market: Emerging Opportunities for Instrument and Reagent Suppliers - Competitive Strategies, Supplier Shares, Country Volume and Sales Segment Forecasts for 100 Tests, Innovative Technologies, Instrumentation
2015-2019 European Infectious Disease Testing Market: Emerging Opportunities for Instrument and Reagent Suppliers - Competitive Strategies, Supplier Shares, Country Volume and Sales Segment Forecasts for 100 Tests, Innovative Technologies, Instrumentation Table of Contents
2015-2019 European Infectious Disease Testing Market is a new five-countrystrategic analysis of major business opportunities emerging in the infectious disease testing market during the nextfive years. The report examines key trends in major European countries (France, Germany, Italy, Spain, UK); reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, market segment, and country; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.
This comprehensive five-country report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies. Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the world’s major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.
Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.
Opportunities and Strategic Recommendations
- Emerging opportunities for new instrumentation, reagents kits, IT and other products with significant market appeal during the next five years.
- Design criteria for decentralized testing products.